Natixis’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.99M | Sell |
8,576
-10,502
| -55% | -$4.42M | 0.02% | 487 |
|
|
2026
Q1 | $7.21M | Sell |
19,078
-1,715
| -8% | -$735K | 0.03% | 359 |
|
|
2025
Q4 | $8.9M | Buy |
20,793
+15,255
| +275% | +$6.64M | 0.03% | 355 |
|
|
2025
Q3 | $2.48M | Buy |
+5,538
| New | +$2.51M | 0.01% | 534 |
|
|
2025
Q1 | – | Sell |
-4
| Closed | -$2.12K | – | 1003 |
|
|
2024
Q4 | $2.12K | Sell |
4
-44
| -92% | -$24.8K | ﹤0.01% | 990 |
|
|
2024
Q3 | $28.8K | Buy |
48
+47
| +4,700% | +$26.6K | ﹤0.01% | 809 |
|
|
2024
Q2 | $543 | Hold |
1
| – | – | ﹤0.01% | 947 |
|
|
2024
Q1 | $642 | Hold |
1
| – | – | ﹤0.01% | 964 |
|
|
2023
Q4 | $585 | Hold |
1
| – | – | ﹤0.01% | 998 |
|
|
2023
Q3 | $520 | Hold |
1
| – | – | ﹤0.01% | 941 |
|
|
2023
Q2 | $542 | Hold |
1
| – | – | ﹤0.01% | 978 |
|
|
2023
Q1 | $538 | Hold |
1
| – | – | ﹤0.01% | 947 |
|
|
2022
Q4 | $510 | Buy |
+1
| New | +$487 | ﹤0.01% | 1047 |
|
|
2022
Q2 | – | Sell |
-1,144
| Closed | -$579K | – | 1181 |
|
|
2022
Q1 | $579K | Sell |
1,144
-9,048
| -89% | -$4.34M | ﹤0.01% | 957 |
|
|
2021
Q4 | $5.39M | Buy |
+10,192
| New | +$4.89M | 0.02% | 542 |
|
|
2021
Q2 | – | Sell |
-19,376
| Closed | -$8.91M | – | 871 |
|
|
2021
Q1 | $8.91M | Buy |
+19,376
| New | +$9.5M | 0.03% | 397 |
|
|
2020
Q3 | – | Sell |
-10,627
| Closed | -$4.79M | – | 780 |
|
|
2020
Q2 | $4.79M | Buy |
+10,627
| New | +$4.74M | 0.04% | 298 |
|
|
2020
Q1 | – | Sell |
-19,616
| Closed | -$8.65M | – | 716 |
|
|
2019
Q4 | $8.65M | Sell |
19,616
-12,005
| -38% | -$5.05M | 0.05% | 307 |
|
|
2019
Q3 | $13.2M | Buy |
31,621
+18,093
| +134% | +$7.39M | 0.09% | 217 |
|
|
2019
Q2 | $4.88M | Buy |
13,528
+10,090
| +293% | +$3.37M | 0.04% | 329 |
|
|
2019
Q1 | $1.1M | Sell |
3,438
-25,005
| -88% | -$7.68M | 0.01% | 573 |
|
|
2018
Q4 | $8.06M | Buy |
28,443
+25,045
| +737% | +$7.56M | 0.07% | 252 |
|
|
2018
Q3 | $1.09M | Buy |
+3,398
| New | +$1.08M | 0.01% | 560 |
|
|
2017
Q2 | – | Sell |
-1,794
| Closed | -$328K | – | 841 |
|
|
2017
Q1 | $328K | Buy |
1,794
+36
| +2% | +$6.28K | ﹤0.01% | 657 |
|
|
2016
Q4 | $282K | Buy |
+1,758
| New | +$258K | ﹤0.01% | 660 |
|
Other funds holding CHE
EIP
Natixis's CHE Position: Q2 2026 in Review
Natixis reduced its Chemed (CHE) stake by 55% in Q2 2026, selling an estimated $4.42M and leaving 8,576 shares worth $3.99M. The position accounts for 0.02% of the portfolio, ranked #487.
Natixis first reported a position in CHE in Q4 2016 and has held it in 25 quarters since. The position peaked at $13.2M in Q3 2019. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.
- Natixis held 8,576 shares of Chemed worth $3.99M as of Q2 2026.
- Natixis sold 10,502 Chemed shares in Q2 2026, an estimated $4.42M.
- Chemed made up 0.02% of Natixis's portfolio in Q2 2026, its #487 holding.
- Natixis first reported a position in Chemed in Q4 2016 and has held it in 25 quarters since.
- Natixis's Chemed position peaked at $13.2M in Q3 2019.
- 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.
Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.